Gross Margin
12.31%vs Specialty Chemicals peers Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives -17.99%.Updated Aug 19, 2026Profit Margin
-93.02%vs Specialty Chemicals peers Updated Aug 19, 2026Operating Margin
-47.49%vs Specialty Chemicals peers Updated Aug 19, 2026Return on Assets (TTM)
-6.13%vs Specialty Chemicals peers Updated Aug 19, 2026Return on Equity (TTM)
-86.64%vs Specialty Chemicals peers Updated Aug 19, 2026Revenue (TTM)
136.63MCNY20.29M · vs all stocks (USD) Updated Aug 19, 2026Revenue per Share (TTM)
0.8080CNYUpdated Aug 19, 2026Quarterly Revenue Growth
14.00%vs Specialty Chemicals peers Updated Aug 19, 2026Gross Profit (TTM)
-24.58MCNY-3.65M · vs all stocks (USD) Updated Aug 19, 2026EBITDA (TTM)
-73.00MCNY-10.84M · vs all stocks (USD) Updated Aug 19, 2026Net Income (TTM)
-127.09MCNY-18.88M · vs all stocks (USD) Updated Aug 19, 2026Quarterly Earnings Growth (YoY)
36.45%vs Specialty Chemicals peers Updated Aug 19, 2026Operating Cash Flow (TTM)
-59.97MCNY-8.91M · vs all stocks (USD) Updated Aug 19, 2026Levered Free Cash Flow (TTM)
-49.45MCNY-7.34M · vs all stocks (USD) Updated Aug 19, 2026Payout Ratio
0.00%vs Specialty Chemicals peers Updated Aug 19, 2026Minority Interest (Equity)
41.33MCNYFY2025 · Dec 31, 2025Revenue
130.36MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
132.25MCNYFY2025 · Dec 31, 2025Gross Profit
-1.89MCNYFY2025 · Dec 31, 2025Operating Income
-96.89MCNY-14.39M · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
-123.19MCNYFY2025 · Dec 31, 2025Income Tax Expense
-457.28KCNYFY2025 · Dec 31, 2025Net Income
-122.73MCNYFY2025 · Dec 31, 2025EBIT
-96.03MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
-12.13MCNYFY2025 · Dec 31, 2025Research & Development
11.95MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
18.33MCNYFY2025 · Dec 31, 2025Other Operating Expenses
899.28KCNYFY2025 · Dec 31, 2025Non-operating Interest Income
1.05MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
27.16MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.7100CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.7100CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
171.61MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
171.61MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-122.73MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
892.07KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-80.89MCNYFY2025 · Dec 31, 2025Free Cash Flow
-125.43MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
189.32MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-122.73MCNYFY2025 · Dec 31, 2025Other Non-cash Items
35.80MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
68.06MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-62.01MCNYFY2025 · Dec 31, 2025Capital Expenditures
44.54MCNYFY2025 · Dec 31, 2025Sale of Investments
1.82MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
46.36MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
155.00MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-87.20MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-18.57MCNYFY2025 · Dec 31, 2025Other Financing Charges
-56.58MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-7.35MCNYFY2025 · Dec 31, 2025